CD8A (Crefmirlimab) Recombinant Monoclonal Antibody

• Gene Aliases:

  Alpha polypeptide (p32) antibody; CD8 antibody; CD8 antigen alpha polypeptide antibody; CD8 antigen alpha polypeptide (p32) antibody; CD8a antibody; CD8A antigen antibody; CD8A molecule antibody; CD8A_HUMAN antibody; Leu2 antibody; Leu2 T lymphocyte antigen antibody; Ly3 antibody; LYT3 antibody; MAL antibody; OKT8 T cell antigen antibody; OTTHUMP00000160760 antibody; OTTHUMP00000160764 antibody; OTTHUMP00000203528 antibody; OTTHUMP00000203721 antibody; p32 antibody; T cell antigen Leu2 antibody; T cell co receptor antibody; T-cell surface glycoprotein CD8 alpha chain antibody; T-lymphocyte differentiation antigen T8/Leu-2 antibody; T8 T cell antigen antibody; T8/Leu-2 T-lymphocyte differentiation antigen antibody

• UniProt:

  P01732

• Antigen Species:

  Human

• Reactivity:

  Human

• Target Antigen:

  Recombinant Human CD8A protein

• Target:

  CD8A

• Clonality:

  Monoclonal

• Conjugation:

  Non-conjugated

• Field of Research:

  Immunology

• Purification Method:

  Affinity-chromatography

• Form:

  Liquid

• Storage Conditions:

  Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

• Antibody Type:

  Recombinant Antibody

• Clone ID:

  9F1

• Tested Applications:

  ELISA; Recommended dilution: ELISA:1:5000-1:50000

• Isotype:

  IgG2